I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Shimose, Takayuki
35
results:
Search for persons
X
Format
Online (35)
Mediatypes
Articles (Online) (24)
OpenAccess-fulltext (11)
Sorted by: Relevance
Sorted by: Year
?
1
Rationale and design of phase II clinical trial of dual inh..:
Kawachi, Hayato
;
Yamada, Tadaaki
;
Yoshimura, Akihiro
...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023
Link:
https://doi.org/10.1177/..
?
2
Phase II study of carboplatin/nab-paclitaxel/atezolizumab c..:
Shiraishi, Yoshimasa
;
Kishimoto, Junji
;
Shimose, Takayuki
...
BMC Cancer. 22 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
3
Phase II study of durvalumab (MEDI 4736) plus carboplatin a..:
Ishii, Hidenobu
;
Azuma, Koichi
;
Shimose, Takayuki
...
Thoracic Cancer. 14 (2022) 1 - p. 105-107 , 2022
Link:
https://doi.org/10.1111/..
?
4
Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Ch..:
Shiraishi, Yoshimasa
;
Shimose, Takayuki
;
Tsuchiya-Kawano, Yuko
...
Cancer Management and Research. 14 (2022) - p. 3449-3453 , 2022
Link:
https://doi.org/10.2147/..
?
5
Effects of pericapsular soft tissue and realignment exercis..:
Hayashi, Kazuo
;
Tsunoda, Toshiharu
;
Tobo, Yuki
..
Current Medical Research and Opinion. 38 (2022) 9 - p. 1567-1578 , 2022
Link:
https://doi.org/10.1080/..
?
6
A Phase II Trial on Osimertinib as a First-Line Treatment f..:
Chihara, Yusuke
;
Takeda, Takayuki
;
Goto, Yasuhiro
...
The Oncologist. 27 (2022) 11 - p. 903-e834 , 2022
Link:
https://doi.org/10.1093/..
?
7
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningea..:
Nosaki, Kaname
;
Yamanaka, Takeharu
;
Hamada, Akinobu
...
The Oncologist. 25 (2020) 12 - p. e1869-e1878 , 2020
Link:
https://doi.org/10.1634/..
?
8
A phase I/II study of S-1 and irinotecan (IRIS) combined wi..:
Samura, Hironori
;
Oki, Eiji
;
Okumura, Hiroshi
...
Cancer Chemotherapy and Pharmacology. 86 (2020) 2 - p. 285-294 , 2020
Link:
https://doi.org/10.1007/..
?
9
Survival Analysis for Patients with ALK Rearrangement-Posit..:
Iwama, Eiji
;
Goto, Yasushi
;
Murakami, Haruyasu
...
The Oncologist. 25 (2019) 4 - p. 306-e618 , 2019
Link:
https://doi.org/10.1634/..
?
10
Longitudinal monitoring of somatic genetic alterations in c..:
Iwama, Eiji
;
Sakai, Kazuko
;
Hidaka, Noriko
...
Cancer. 126 (2019) 1 - p. 219-227 , 2019
Link:
https://doi.org/10.1002/..
?
11
Skeletal muscle loss during systemic chemotherapy for color..:
Sasaki, Shun
;
Oki, Eiji
;
Saeki, Hiroshi
...
International Journal of Clinical Oncology. 24 (2019) 10 - p. 1204-1213 , 2019
Link:
https://doi.org/10.1007/..
?
12
Cessation of nilotinib in patients with chronic myelogenous..:
Nagafuji, Koji
;
Matsumura, Itaru
;
Shimose, Takayuki
...
International Journal of Hematology. 110 (2019) 6 - p. 675-682 , 2019
Link:
https://doi.org/10.1007/..
?
13
Comparison of computed tomography imaging analyses for eval..:
Hirose, Kosuke
;
Oki, Eiji
;
Shimose, Takayuki
...
International Journal of Clinical Oncology. 24 (2019) 11 - p. 1397-1405 , 2019
Link:
https://doi.org/10.1007/..
?
14
Exploration of resistance mechanisms for epidermal growth f..:
Iwama, Eiji
;
Sakai, Kazuko
;
Azuma, Koichi
...
Cancer Science. 109 (2018) 12 - p. 3921-3933 , 2018
Link:
https://doi.org/10.1111/..
?
15
Efficacy and safety of switching to nilotinib in patients w..:
Ishikawa, Jun
;
Matsumura, Itaru
;
Kawaguchi, Tatsuya
...
International Journal of Hematology. 107 (2018) 5 - p. 535-540 , 2018
Link:
https://doi.org/10.1007/..
1-15